Feasibility Study of Intratumoral NRF2 Expression as a Predictive Biomarker for the Effectiveness of Immunotherapy in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitor.

Saved in:
Bibliographic Details
Title: Feasibility Study of Intratumoral NRF2 Expression as a Predictive Biomarker for the Effectiveness of Immunotherapy in Patients with Non-Small Cell Lung Cancer Treated with PD-1 Inhibitor.
Authors: Jin, Yasuto1 (AUTHOR) yasutojinn@kkr.hiratsuka.kanagawa.jp, Inoue, Yukihisa1,2 (AUTHOR), Shimada, Hiroyuki1 (AUTHOR), Hara, Tetsu1,2 (AUTHOR), Yamashita, Shohei1 (AUTHOR), Yamamoto, Mio1 (AUTHOR), Matsubara, Osamu2 (AUTHOR)
Source: Cancers. Jul2026, Vol. 18 Issue 14, p2202. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18142202